Additionally, we conducted differential expression analysis, immune cell infiltration assessment, and immune checkpoint analysis on pan-cancer datasets to determine the effect of PITX1 on tumor-infiltrating cells (TICs) across various cancer types. Here, PITX1 is linked to neoplasm.